Pathological Types,Expression of Mismatch Repair Protein,Human Epidermal Growth Factor Receptor 2,and Pan-TRK,and Eostein-Barr Virus Infection in Patients With Colorectal Cancer Resected in Tibet.
10.3881/j.issn.1000-503X.15343
- Author:
Han-Huan LUO
1
;
Zhen HUO
2
;
BIANBAZHAXI
3
;
Qian WANG
1
;
DUOBULA
1
;
NIMAZHUOMA
1
;
Zhen DA
1
;
Ping-Ping GUO
1
Author Information
1. Department of Pathology,Tibet Autonomous Region People's Hospital,Lhasa 850000,China.
2. Department of Pathology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.
3. Department of General Surgery,Tibet Autonomous Region People's Hospital,Lhasa 850000,China.
- Publication Type:Journal Article
- Keywords:
Epstein-Barr virus;
Pan-TRK;
Tibet;
colorectal cancer;
human epidermal growth factor receptor 2;
mismatch repair protein;
pathological type
- MeSH:
Adult;
Aged;
Female;
Humans;
Male;
Middle Aged;
Adenocarcinoma;
Biomarkers, Tumor/genetics*;
Colorectal Neoplasms/pathology*;
DNA Mismatch Repair;
DNA-Binding Proteins/genetics*;
Epstein-Barr Virus Infections/diagnosis*;
Herpesvirus 4, Human/metabolism*;
In Situ Hybridization, Fluorescence;
Lymphatic Metastasis;
Tibet;
Young Adult;
Aged, 80 and over
- From:
Acta Academiae Medicinae Sinicae
2023;45(3):422-428
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the pathological types,expression of mismatch repair protein,human epidermal growth factor receptor 2(HER2),and Pan-TRK,and Epstein-Barr virus(EBV)infection in patients with colorectal cancer resected in Tibet. Methods A total of 79 patients with colorectal cancer resected in Tibet Autonomous Region People's Hospital from December 2013 to July 2021 were enrolled in this study.The clinical and pathological data of the patients were collected.The expression of mismatch repair protein,HER2,and Pan-TRK was detected by immunohistochemical(IHC)staining,and detection of HER2 gene by fluorescence in situ hybridization(FISH)in the patients with HER2 IHC results of 2+ or above.EBV was detected by in situ hybridization with EBV-encoded small RNA. Results A total of 79 colorectal cancer patients were included in this study,with the male-to-female ratio of 1.26:1 and the mean age of(57.06±12.74)years(24-83 years).Among them,4 patients received preoperative neoadjuvant therapy.Colonic cancer and rectal cancer occurred in 57(57/79,72.15%,including 31 and 26 in the right colon and left colon,respectively)and 22(22/79,27.85%)patients,respectively.The maximum diameter of tumor varied within the range of 1-20 cm,with the mean of(6.61±3.33)cm.Among the 79 colorectal cancer patients,75(75/79,94.94%)patients showed adenocarcinoma.Lymph node metastasis occurred in 12(12/21,57.14%)out of the 21 patients with severe tumor budding,13(13/23,56.52%)out of the 23 patients with moderate tumor budding,and 2(2/31,6.45%)out of the 31 patients with mild tumor budding,respectively.The lymph node metastasis rate showed differences between the patients with severe/moderate tumor budding and the patients with mild tumor budding(all P<0.001).The IHC staining showed that mismatch repair protein was negative in 10(10/65,15.38%)patients,including 5 patients with both MSH2 and MSH6 negative,4 patients with both MLH1 and PMS2 negative,and 1 patient with MSH6 negative.Pan-TRK was negative in 65 patients.The IHC results of HER2 showed 0 or 1+ in 60 patients and 2+ in 5 patients.FISH showed no positive signal in the 5 patients with HER2 IHC results of 2+.The detection with EBV-encoded small RNA showed positive result in 1(1/65,1.54%)patient. Conclusions Non-specific adenocarcinoma of the right colon is the most common in the patients with colorectal cancer resected in Tibet,and 15% of the patients showed mismatch repair protein defects.EBV-associated colorectal carcer is rare,Pan-TRK expression and HER2 gene amplification are seldom.The colorectal cancer patients with moderate and severe tumor budding are more likely to have lymph node metastasis.
